AbbVie (ABBV) and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ASML
2. USO
3. LAD
4. ROIV
5. DKNG
6. BSX
7. ODFL
8. NVS
9. AHR
10. ALV

Go back to AbbVie (ABBV) and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
AbbVie (NYSE: ABBV) Delayed: 256.46 --0 (-0%)
Previous Close $256.46    52 Week High $68.12 
Open $256.46    52 Week Low $50.71 
Day High $256.46    P/E 55.63 
Day Low $256.46    EPS $4.61 
Volume 4,177